An Attempt to Induce Transient Immunosuppression Pre-Erythrocytapheresis in a Girl with Sickle Cell Disease, a History of Severe Delayed Hemolytic Transfusion Reactions and Need for Hip Prosthesis
Open Access
- 28 June 2013
- journal article
- Published by MDPI AG in Hematology Reports
- Vol. 5 (2) , 36-8
Abstract
We report on a case of delayed hemolytic transfusion reaction (DHTR) occurred 7 days after an erythrocytapheresis or eritroexchange procedure (EEX) treated with rituximab and glucocorticoids in a 15-years old patient with sickle cell disease. EEX was performed despite a previous diagnosis of alloimmunization, in order to reduce hemoglobin S rate before a major surgery for avascular necrosis of the femoral head. A first dose of rituximab was administered before EEX. However, rituximab couldn’t prevent DHTR that occurred with acute hemolysis, hemoglobinuria and hyper-bilirubinemia. A further dose of rituximab and three boli of methylprednisolone were given after the onset of the reaction. It is likely that the combined use of rituximab and steroids managed to gradually improve both patient’s general conditions and hemoglobin levels. Nor early or late side effects were registered in a 33-months follow-up period. This report suggests the potential effectiveness and safety of rituximab in combination with steroids in managing and mitigating the symptoms of delayed post-transfusional hemolytic reactions in alloimmunized patients affected by sickle cell disease with absolute need for erythrocytapheresis.Keywords
This publication has 15 references indexed in Scilit:
- Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemiaAmerican Journal of Hematology, 2009
- Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion—severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximabTransfusion, 2009
- B-Cell Depletion for Autoimmune Thrombocytopenia and Autoimmune Hemolytic Anemia in Pediatric Systemic Lupus ErythematosusPediatrics, 2009
- B cell-targeted therapy with rituximab and autoimmune neuromuscular disordersJournal of Neuroimmunology, 2008
- Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell diseaseHaematologica, 2007
- Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesisNature Clinical Practice Rheumatology, 2007
- Bystander Immune CytolysisTransfusion Medicine Reviews, 2006
- Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell DiseasePediatrics, 2003
- Rituximab for the treatment of refractory autoimmune hemolytic anemia in childrenBlood, 2003
- Perioperative management for cholecystectomy in sickle cell diseaseJournal of Pediatric Surgery, 1993